IIR’s Specialty Pharmacy Collaboration Summit · Pre-Conference Workshop • Monday, September...
-
Upload
nguyenhanh -
Category
Documents
-
view
214 -
download
0
Transcript of IIR’s Specialty Pharmacy Collaboration Summit · Pre-Conference Workshop • Monday, September...
Specialty Pharmacy Collaboration Summit
September 15-17, 2014 | Omni Parker House | Boston, MA
Partner to expand distribution, increase patient adherence and improve your bottom line
www.IIRSpecialtyPharmacySummit.com @healthcarebiz #SPCS14
IIR’s
NEVER-BEFORE-HEARD CASE STUDIES Accountable Care Impact on Payer
Provider Relations from Aetna, BCBS,
Tufts Health Plan, Denver Health
Medical Plan and more!
URAC AND CPPA ACCREDITATION WORKSHOPImprove operations and enhance
compliance with URAC & CPPA
Specialty Pharmacy Accreditations.
INTRODUCING
Facilitate more face-to-face meetings
in 3 days across the specialty pharmacy
ecosystem than in your entire year!
Ray Tancredi, RPh, MBA, CSP
VP, Specialty Pharmacy Development Walgreens Co.
Gregory W. Daniel,
Managing Director, and Fellow, Engelberg Center for Health Care Reform, Brookings Institution
Robert Popovian
Senior Director, US Government RelationsPfizer Pharmaceuticals
Reed Melton
Executive Director, Center for Clinical Practices Blue Cross and Blue Shield Association
HEAR EXPERTS FORECAST GROWTH & TRENDS AS THE AFFORDABLE CARE ACT REDEFINES THE INDUSTRY
Pre-Conference Workshop • Monday, September 15, 2014
URAC AND CPPA SPECIALTY PHARMACY ACCREDITATION WORKSHOP
Main Conference Day One • Tuesday, September 16, 2014
8:15 Registration Opens & Morning Coffee
8:45 Chairperson’s Welcome & Opening Remarks
Specialty Pharmacy: Evolving to Meet Patient Needs and Healthcare Challenges
Ray Tancredi, RPh, MBA, CSP, VP, Specialty Pharmacy Development, WALGREENS CO.
9:30 The True Value of Specialty Pharmacy: A Direct Impact on Bottom Line Revenue and Profits
This session will give you a 360° perspective on the impact of specialty pharmacies on bottom line profits and costs. As the industry comes under scrutiny for unprecedented profit margins and transferring cost burdens onto patients; hear from leaders in the space as they discuss the implications of strategies used internally and the implicit bottom line benefits.
Reed Melton, Executive Director, Center for Clinical Practices, BLUE CROSS AND BLUE SHIELD ASSOCIATION
Bhavesh Shah RPh, BCOP, Hematology/Oncolgoy Pharmacy Manager, BOSTON MEDICAL CENTER
10:15 Specialty Pharmacy Management in Commercial Health Plans
PAYERPANEL
This payer panel discussion will shed light on commercial plan strategies and priorities as collaboration with specialty pharmacies and pharma becomes integral to their success.
• What are payers’ top specialty pharmacy priorities and management goals?
• How does payer management intensity vary by therapeutic category?
• How does payer focus on cost management versus clinical management vary by specialty category?
Michelle Beozzo, PharmD, Director of Pharmacy Services, Managed Care, DENvER HEALTH MEDICAL PLAN
@healthcarebiz #SPCS14
URAC Accreditation 9:00 Workshop Starts
10:00 Morning Networking Break
URAC’s Specialty Pharmacy Accreditation provides an external validation of excellence in Specialty Pharmacy Management and provides Continuous Quality Improvement (CQI) oriented processes that improve operations and enhance compliance. It also helps to assist in preparing for regulatory compliance.
Key Takeaways:
• Learn how accreditation creates a pathway by which a pharmacy can build specialty pharmacy capabilities
• Develop a patient-centered specialty drug management approach
• Learn how to improve processes and procedures, promoting operational efficiencies while ensuring the highest level of customer service for a specialty pharmacy
• Understand how to build your specialty pharmacy business on quality benchmarks and performance outcome measures
Janice Anderson, Director Pharmacy Programs, URAC
10:30 Workshop continues
12:00 Workshop continues Networking Lunch
Center For Pharmacy Practice Accreditation
1:00 Meet the New Accreditor: Center for Pharmacy Practice Accreditation® (CPPA®)
The Center for Pharmacy Practice Accreditation® (CPPA®) is a partnership established by the American Pharmacists Association (APhA), the National Association of Boards of Pharmacy (NABP), and the American Society of Health-System Pharmacists (ASHP) to provide accreditation for pharmacy practice sites. CPPA® accredits those pharmacy practices that deliver high quality, safe and efficient patient care services.
Presentation Highlights:
• What makes CPPA® unique in the specialty pharmacy
accreditation market
• The four primary areas of specialty pharmacy practice (standard domains) which encompass the overall provision of care. The presentation will review the o Standards development process o The accreditation standards o The metrics and reports required for accreditation
Lynnae M Mahaney, BSPharm, MBA, FASHP, Executive Director, CPPA®
Terri Smith Moore, PhD, MBA, R.Ph, Consultant, MOORE ASSOCIATES
2:00 The Accreditation Experience: Duke University Medical Center
Duke University Medical Center became the first beta site to vet the CPPA® Pharmacy Practice accreditation process. Learn about their experience.
Paul Bush, PharmD, MBA, FASHP, BCPS, Chief Pharmacy Officer, DUkE UNIvERSITy HOSPITAL
3:15 Community/Specialty Pharmacy Practice Accreditations for Distribution Channel Partners
Gary Rice, Vice President, Clinical Services, DIPLOMAT
Accreditation brings value along the medication management continuum of care involving multiple pharmacy practice providers. Accreditation is a valuable asset in Diplomat’s unique delivery model of specialty pharmacy care.
4:00 Specialty Pharmacy Practice Accreditation and the Payer
Learn how CPPA accreditation is a differentiating factor for preferred pharmacy networks and aligns with the quality initiatives in the healthcare marketplace and payer goals.
Anthony Staresinic, Director of Pharmacy, UNITy HEALTH POINT
4:45 Wrap-Up
www.IIRSpecialtyPharmacySummit.com
Call: 888.670.8200 • Email: [email protected]
URAC AND CPPA SPECIALTY PHARMACY ACCREDITATION WORKSHOP David Brumley, MD, MBA, Senior Medical Director, TUfTS HEALTH PLAN
Pavel Lavitas, PharmD, BCPS, Clinical Consultant Pharmacist, UMASS MEDICAL SCHOOL, CLINICAL PHARMACy SERvICES
11:00 Networking Break
11:15 What Is the Value of High Cost Specialty Medicines?
KEYNOTE
Health care payment systems are evolving, where there is a greater emphasis on global payments tied to quality performance. In this session, Robert will discuss the optimal methodologies to assess the value and cost proposition of specialty medicines in the evolving payment policy environment by discussing the importance of:
• Defining quality measures for specialty medicines • Ensuring global payment models which encapsulate all
costs and outcomes including those for pharmaceuticals• Developing measures of quality and value that are relevant
to patients
Robert Popovian, Senior Director, US Government Relations, PfIzER PHARMACEUTICALS
12:00 Networking Lunch
1:00 Optimize the Patient Experience Specialty pharmacy has advanced over the years to better
meet patients’ needs receiving specialty medications as advancements in medication treatment are continually evolving and improving. The “high-touch” patient care approach goes beyond advanced care clinical models and now also includes the in-take process and gaining patient access via prior approval, appeals, and patient financial support to gain access to the medication. Key take-a-ways from the presentation includes:
• The patient journey from a new prescription, a refill, and medication compliance program examples.
• Explain the infrastructure, administrative requirements, and effective practices for managing “high-touch” patient care.
• Identify possible methods for data collecting of health outcomes in a specialty pharmacy.
Gary Rice, RPh, MS, MBA, CSP, Vice President, Clinical Services, DIPLOMAT
1:45 From Raw Data to Big Data: The Value of Data Management
As the growing specialty pharmacy niche is becoming a major force in the health care industry, the need to effectively manage ever more complex data has become a challenge. This session will run you through the importance of aggregating data and measuring outcomes for all stakeholders — patients, pharmacies, prescribers, manufacturers and insurers.
• The feasibility of transparency & stakeholder collaboration• How to manage complex data & turn it into driven
decisions
Donna Trane,VP Business Development, ACCREDO HEALTH GROUP
2:30 Networking Break
2:45 Under the Microscope ROUNDTABLE
Managing the cost of these extremely expensive and essential specialty drugs is key to patients. This roundtable gives you the opportunity to hone in on the specifics of each of these life threatening diseases. Hear our roundtable leaders as they shed light on their expertise with each of these disease states:
Roundtable 1: Multiple Sclerosis
Roundtable 2: Cancer
Chris Fausel, Head of Pharmacy for Oncology, IU HEALTH CANCER CENTER
Roundtable 3: Hepatitis C
Stephanie Padoan RN, BSN, MS, Director of Clinical Strategy and Development, AETNA
3:45 Impact of ACOs and Issues of Fragmentation of Care
This session will discuss:
• ACOs and their impact on specialty pharmacy• The role of academic medical centers on the effective
management of population risk and healthcare cost• Current issues with fragmentation of care• The role of integrated practice units
Kevin J. Colgan, R.Ph., MA, Director of Pharmacy, RUSH UNIvERSITy MEDICAL CENTER
4:30 Close of Conference Day One
Main Conference Day One • Tuesday, September 16, 2014
Main Conference Day Two • Wednesday, September 17, 2014
9:00 Registration Opens & Morning Coffee
9:15 Chairperson’s Recap of Day One
9:45 Embracing the Affordable Care Act for Specialty Pharmacy
Gregory W. Daniel, Managing Director and Fellow, Engelberg Center for Health Care Reform, THE BROOkINGS INSTITUTION
10:15 Changing the Channel: A Pharmaceutical Distribution Perspective
Today, specialty pharmaceuticals are special indeed: they are dominating pipelines, and their sales are forecasted to grow at twice the rate of traditional products for the next
five years, but with such rapid growth comes equally rapid change.
• What strategies can help companies sustain their commercial success?
• Develop sound distribution strategies • How to position within the channel to gain a competitive
advantage
Richard Peters, MD, PhD, Strategy Development Officer, GENzyME
Sylvia Bartel, VP Pharmacy, DANA-fARBER CANCER INSTITUTE, HARvARD UNIvERSITy
11:00 Networking Break
REGISTER TODAY!
© 2014 Institute for International R
esearch, Inc. All rights reserved
www.IIRSpecialtyPharmacySummit.com
11:15 Has The Generic Wave and Specialty Boom Restructured the U.S. Pharmacy Industry Forever?
EXCL-USIVE
This session will open you up to a full fledged debate from industry leaders who understand the benefits of both the ‘generics wave’ and the ‘specialty boom’. This never-before-heard session discusses the strategic and tactical steps decision makers need to hop on to the bandwagon and reap the bottom line benefits.
12:00 Networking Lunch
1:00 The Specialty Pharmacy Space—Niche No More?
ROUNDTABLE
In addition to the many pharmacies that already have specialty capabilities, new sources of competition are rapidly emerging. This roundtable allows you to ‘pick your poison’ and join the discussion most relevant to you!
Roundtable 1: Independent Retail Community Pharmacies
Nick Calla, VP Industry Relations, COMMUNITy SPECIALTy PHARMACy NETWORk
Roundtable 2: Regional and National Chains Launching Specialty at Retail Programs
Christopher Benz, Business Development Director, ARMADA HEALTH CARE
Brian Burke, Vice President, National Accounts, ARMADA HEALTH CARE
Roundtable 3: Private, Independent Specialty Pharmacies
Rebecca M. Shanahan, Esq. Chief Executive Officer, AvELLA SPECIALTy PHARMACy
2:00 How Will Specialty Pharmacy Evolve in A Risk-Sharing Environment?
This session will touch on
• Specialty Therapy Management• Adherence• Cost Management
Mike Reilly, President, Pharmacy Benefit Dimensions, INDEPENDENT HEALTH
2:45 Is the SP Advantage Sustainable?
PANEL There is no one single answer to how to best manage this category of drugs, and the impact of these agents on the overall medical cost curve is still somewhat unknown. For instance, will some chronic diseases ultimately cost the system less due to the potential for specialty drugs to modify the course of a chronic disease? Or, will these potential cost savings be outweighed by a growing number of patients living longer with chronic conditions. This closing panel will discuss the:
• Challenges of effectively managing this benefit and the costs associated with it .
• What will be the impact of biosimilars?• What does the future hold?
Panelists:
Mike Reilly, President, Pharmacy Benefit Dimensions, INDEPENDENT HEALTH
3:30 Chairperson’s Closing Remarks & Close of Conference
3 Easy Ways to RegisterEASIEST! www.IIRSpecialtyPharmacySummit.com
Call: 888.670.8200 US
Email: [email protected]
Pricing & hotel
Main Conference Day Two • Wednesday, September 17, 2014
Save $600 Save $400 Save $200
Pharma, Biotech, Specialty Pharmacies, Solution Providers By 6/27/14 By 7/25/14 By 8/22/14 Standard Rate
Main Conference + Pre-Conference Workshop
$2,595 $2,795 $2,995 $3,195
Main Conference $1,795 $1,995 $2,195 $2,395
Save $400 Save $200
Health Plans By 7/25/14 By 8/22/14 Standard Rate
Main Conference + Pre-Conference Workshop
$1,595 $1,795 $1,995
Main Conference $795 $995 $1,195
SAvE 10%
Off the current rates for teams of 3-5
Off the current rates for teams of 6-8
Please contact Millison Thenor at [email protected] or 646-616-7625 to customize a registration package!
SAvE 15%
GROUPS of 9+
Team & Group Discounts
IIR’s Specialty Pharmacy Collaboration Summit is designed for teams! There is too much information available for just one person to capture it all. Plus, attendees of a conference walk away with the most value when they experience it with a peer.
For complete registration, discount, payment and cancellation policies, visit: www.IIRSpecialtyPharmacySummit.com
@healthcarebiz #SPCS14
HOTEL Omni Parker House60 School StreetBoston, MA(617) 227-8600
Room Rate is $299/night + tax. Call 1-800-THE-OMNI; deadline is August 15, 2014 or until sold out.
REGISTER TODAY! Call: 888.670.8200 • Email: [email protected]
Dear Colleague,
Increasing health care costs backed by the reforms and changes brought about by Health Care Reforms and the ACA are a continuing challenge for all stakeholders within the health care landscape. Payers’ efforts to reduce costs and keep their premiums competitive in order to maintain profitability also put pressure on providers and patients.
Providers are facing declining reimbursement and rising costs as they work to keep their doors open, while patients are facing increased cost shares for drugs and services—particularly for high-cost specialty products. Adding to the stakeholder challenges is the continued development of highly complex, high-cost specialty therapies and the distribution of these drugs.
IIR’s Specialty Pharmacy Collaboration Summit is the only event in the industry bringing together all critical stakeholders in the specialty pharmacy value chain, including the leading pharmaceutical companies, health plans, and specialty pharmacies as the landscape develops year on year.
“By 2013, global revenue from specialty products will exceed $160 billion.” IMS Health
Join us in September as we convene to provide you with a roadmap for managing the future impact of specialty pharmacies. I look forward to seeing you there!
Kind Regards,
Sakina Hussain
Conference Director
IIR’s Specialty Pharmacy Collaboration Summit
P.S. IIR’s Specialty Pharmacy Collaboration Summit is designed to facilitate
networking, collaboration and integration between all key stakeholders
in the evolving Specialty Pharmacy value chain. Register your whole
team and save up to 15% off the current registration rates! Contact Millison
Thenor today at 646.616.7625 to develop a customized registration package
for your team!
IIR’s
NEW! INTRODUCING
Engage in pre-event discussions, view
who is attending and arrange one-to-
one meetings with partnering360®.
Foster meaningful engagement and build
relationships with key stakeholders in
the specialty pharmacy value chain to
achieve your personal objectives and your
company’s collaborative aims.
WHO SHOULD ATTEND
Pharma, Specialty Pharmacy, and Biotech: • Managed Markets
• Market Access
• Managed Care
• National Accounts
• Regional Accounts
Health Plans:• Medical Director
• VP / Director / Managers of Pharmacy
Specialty Pharmacy & PBM’s • VP / Director / Managers of Specialty
Pharmacy
• VP / Directors of Pharmacy Services
• Pharmacy Benefit Manager
BUILD RELATIONSHIPS WITH DECISION MAkERS
To learn how to sponsor or exhibit, please contact Patricia Rose at 508-614-1406 or [email protected].
MEDIA PARTNERS (AS Of 3.31.14)
Specialty Pharmacy Collaboration Summit
Introducing
Powered by partnering360, this collaborative summit is designed to facilitate networking and integration between all key stakeholders in the evolving specialty pharmacy value chain. Efficiently meet with the right people and navigate the increasingly complex, yet essential relationship between payers, pharma manufacturers and specialty pharmacies. With partnering360, you can:
EngagE in pre and post event discussions
viEw who is attending the event
arrangE one-to-one meetings
Specialty Pharmacy Collaboration Summit
September 15-17, 2014 | Omni Parker House | Boston, MA
Partner to expand distribution, increase patient adherence and improve your bottom line
SAVE UP TO $400 off the Standard
Registration Rates by 7/25
IIR’s
www.IIRSpecialtyPharmacySummit.com
Specialty Pharmacy Collaboration Summit
IIR’s
September 15-17, 2014Omni Parker House | Boston, MA
www.IIRSpecialtyPharmacySummit.com
Institute for International Research708 Third AveNew York, NY 10017
P1968
All new!
Why Attend?Collaborate with manufacturers, insurance plans and specialty pharmacies to develop consistency and clarity around the integration of all stakeholders in the Specialty Pharmacy value chain.
Payer/Health PlansPartner for additional options to better manage your costs,patient adherence and utilization — while maintaining your bottom line.
Pharma ManufacturersGain insights into the growing Specialty Pharmacy industry, and get access to controlled or closed distribution channels for specialty drugs.
Specialty PharmaciesShowcase how your infrastructure can provide immediate insight into patient compliance, side-effect tracking, and targeted management of specialty drugs while controlling health care costs.
Route to Manager / Director:• Regional / National Accounts• Managed Markets• Pharmacy
@healthcarebiz #SPCS14